Enhanced Confidence in the Safety and Efficacy of Viral Gene Editing

Current approaches to characterizing lentiviral and AAV-mediated gene therapies may miss insertional mutagenesis and correlated gene expression changes. Read our perspective on how emerging single-cell multiomics technologies put more comprehensive data in researchers' hands.

In this white paper, you'll read about:

  • How characterizing transgene insertion and expression can improve cell and gene therapy development
  • The deleterious effects of genomic and transcriptomic changes possible as a result of insertional mutagenesis
  • Why single-cell multiomic analysis is necessary to characterize and validate viral gene therapy candidates
  • Tools that make it possible to precisely, sensitively detect insertions, deletions, substitutions, larger genomic alterations, alternative splicing events, and altered gene expression across the entire genome – and attribute these variants to individual cells.
Cells Explored. Answers Revealed.
By sharing your email address with us, you agree to receive occasional emails from BioSkryb Genomics, Inc. You can unsubscribe at any time.

Schedule a consultation